Revolutionizing 3D Cell Culture with RASTRUM™ Allegro
Inventia Life Science, an innovator in 3D cell culture technologies, has announced an exciting advancement designed to transform the landscape of drug discovery and disease research. The latest addition, RASTRUM™ Allegro, is engineered to enhance scalability and efficiency in high-throughput cell culture, addressing critical challenges faced by researchers worldwide.
Breaking Barriers in Cell Culture Technology
RASTRUM Allegro is a game-changer for scientists who strive for authentic biological models vital for meaningful research outcomes. Many researchers encounter difficulties with traditional 3D culture systems, particularly when it comes to consistent results and the availability of patient-derived cells. This new platform not only facilitates easier creation of complex three-dimensional cell models but also minimizes the hands-on time required, thereby making advanced biological studies more attainable for various laboratories.
Precision and Scalability for Enhanced Research
Julio Ribeiro, Founder and CEO of Inventia Life Science, emphasizes the importance of biologically relevant models in scientific research. He stated, "With RASTRUM Allegro, we empower researchers to create intricate 3D models that mirror human biology. This system is designed to provide the precision and scalability needed to yield deeper insights and drive innovation in biomedical studies."
Significant Improvements in Cost and Time Efficiency
One of the standout features of RASTRUM Allegro is its ability to produce high-throughput 3D cell culture assays quickly and affordably. By slashing the costs associated with each sample, researchers can investigate a wider array of variables, consequently gaining more significant insights, all while ensuring consistent data across their experiments.
Alignment with Inventia's Mission
The release of RASTRUM Allegro aligns perfectly with Inventia's goal of enhancing biomedical research. The company is dedicated to creating tools that reliably simulate disease biology at scale. As Ribeiro pointed out, "Our commitment is to enable researchers to unveil new biological insights confidently. RASTRUM Allegro builds on solid technology, supporting labs in adopting advanced 3D models without sacrificing quality or accessibility."
Transformational Impact on Drug Discovery Processes
RASTRUM Allegro is redefining workflows in drug screening and disease modeling. Cameron Ferris, PhD, COO at Inventia Life Science, expressed that this innovation eliminates the long-standing dilemma researchers faced between maintaining biological complexity and achieving required scalability. The system allows for high-throughput 3D cell culture while ensuring the reproducibility that matches traditional 2D systems.
Opportunities for Deeper Biological Insights
The introduction of RASTRUM Allegro brings a range of benefits, including:
- Speed and Scalability: Rapid production of 3D cell models, achieving 96-well plates in just 6 minutes and 384-well plates in 9 minutes, with the potential to handle over 35 plates daily.
- High Reproducibility: Consistency in results is guaranteed for both basic research and drug discovery efforts, with post-print coefficients of variation below 10% and downstream assay CVs under 19%.
- Enhanced Efficiency: Optimally designed for patient-derived samples, allowing researchers to build up to 3.5 times more cell models than previous technologies permitted.
- Cost Effectiveness: Reducing costs per well makes 3D culture techniques more widely accessible to research labs.
Looking Towards a Bright Future in Research
RASTRUM Allegro signals not just a technological innovation—it marks a significant shift towards democratizing access to advanced 3D cell culture among researchers everywhere. Ribeiro summarized this vision with optimism: "This represents a generational leap for research initiatives and overall human health. We are setting the stage for 3D cell culture to become an everyday resource in labs globally, unlocking new avenues in understanding diseases and developing therapies."
About Inventia Life Science
Inventia Life Science continues to pioneer 3D cell culture technologies through innovative platforms and comprehensive Discovery Services. The company aims to enable researchers and pharmaceutical firms to investigate cell behaviors in environments closely imitating human physiology. By integrating state-of-the-art 3D cell model architectures and precision drop-on-demand technology, Inventia promotes a more profound comprehension of complex biological systems. Offering a full suite of customized services enhances its partners' capabilities throughout their research journeys. Inventia Life Science strives to furnish solutions that yield reproducible results on a large scale, expanding what's achievable in understanding health and disease.
Frequently Asked Questions
What is RASTRUM Allegro?
RASTRUM Allegro is an advanced 3D cell culture technology designed by Inventia Life Science to enhance drug discovery and disease research.
What are the key benefits of RASTRUM Allegro?
Key benefits include speed, scalability, reproducibility, efficiency, and cost-effectiveness in producing 3D cell cultures.
How does RASTRUM Allegro improve research workflows?
The system eliminates traditional trade-offs between biological complexity and scalability, allowing for high-throughput assays that maintain data consistency.
Who would benefit from using RASTRUM Allegro?
Researchers in the fields of drug discovery and biomedical studies can greatly benefit from RASTRUM Allegro by gaining deeper insights through advanced 3D modeling.
What is Inventia Life Science’s mission?
Inventia Life Science’s mission is to advance biomedical research by providing innovative tools that accurately simulate disease biology at scale.
